Taraval Associates specializes in new venture development in selected high-technology industries, especially health care and biotechnology.  We help solve problems common to most new ventures.  The scope of Taraval Associates’ work ranges from the evaluation of new business opportunities to the formation of new technology-based companies.  Our new venture development practice, together with our many years of operating experience, led us into the seed capital, early-stage venture business.

From time to time, we are asked to assist with strategy development and program implementation.  We are often then retained to participate in the day-to-day execution of the tasks that we prescribe.  Because we have substantial operating experience on the inside of start up and emerging growth companies, we can be counted on to overcome common problems found in many start-up and emerging companies.  This hands-on approach leads to successful implementation of winning business strategies.

Taraval Associates has completed assignments for a wide range of companies.  As entrepreneurism has spread around the world, so our reach has become increasingly more international.  Our client list reflects both the breath of our work and our geographical reach.  Among our many clients, we include:

  • Amoco Technology Company
  • Anchor Products/New Zealand Dairy Group
  • Ben Venue Laboratories (Boehringer Ingelheim)
  • Bessemer Venture Partners
  • BioTransplant
  • Charter Venture Capital
  • COR Therapeutics
  • EndoTherapeutics
  • EP Technologies
  • Integrated Device Technologies
  • John Hancock Capital Growth Management
  • LaserScope
  • Salmon Smith BioLabs (NZ)
  • Stem Cell Sciences PLC
  • Ultrox International
  • Varian Associates
  • Virtual Medicine